FUS fibrillation occurs through a nucleation-based process below the critical concentration required for liquid–liquid phase separation

Emilie Bertrand (1) , Clément Demongin (1) , Ioana Dobra (1) , Juan-Carlos Rengifo-Gonzalez (1) , Anastasia S Singatulina (1, 2) , Maria V Sukhanova (2) , Olga I Lavrik (2) , David Pastré (1) , Loic Hamon (1)

1 SABNP - Structure et activité des biomolécules normales et pathologiques
2 ICBFM SB RAS - Institute of Chemical Biology and Fundamental Medicine [Novosibirsk, Russia]

Abstract FUS is an RNA-binding protein involved in familiar forms of ALS and FTLD that also assembles into fibrillar cytoplasmic aggregates in some neurodegenerative diseases without genetic causes. The self-adhesive prion-like domain in FUS generates reversible condensates via the liquid–liquid phase separation process (LLPS) whose maturation can lead to the formation of insoluble fibrillar aggregates in vitro, consistent with the appearance of cytoplasmic inclusions in ageing neurons. Using a single-molecule imaging approach, we reveal that FUS can assemble into nanofibrils at concentrations in the nanomolar range. These results suggest that the formation of fibrillar aggregates of FUS could occur in the cytoplasm at low concentrations of FUS, below the critical ones required to trigger the liquid-like condensate formation. Such nanofibrils may serve as seeds for the formation of pathological inclusions. Interestingly, the fibrillation of FUS at low concentrations is inhibited by its binding to mRNA or after the phosphorylation of its prion-like domain, in agreement with previous models.

Domaines: Sciences du Vivant [q-bio]

Emilie Bertrand, Clément Demongin, Ioana Dobra, Juan-Carlos Rengifo-Gonzalez, Anastasia S Singatulina, et al.. FUS fibrillation occurs through a nucleation-based process below the critical concentration required for liquid–liquid phase separation. Scientific Reports, 2023, 13 (1), pp.7772. ⟨10.1038/s41598-023-34558-1⟩. ⟨hal-04231423⟩